World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Italy
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
101
Citations
38368
World Ranking
1436
National Ranking
21

Stefano Ferrari publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Stefano Ferrari sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 559 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Stefano Ferrari D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Stefano Ferrari sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 101 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Italy Leader Award

Overview

Stefano Ferrari is affiliated with the Veneto Eye Bank Foundation in Italy. Their research spans predominantly the field of Medicine, with a focus on Reproductive Medicine, Obstetrics and Gynecology, Pulmonary and Respiratory Medicine, Oncology, and Materials Chemistry. Their scholarly output covers a wide range of topics related to reproductive and gynecological health, cancer treatment, and chemical applications in medicine.

Major research topics addressed by Ferrari include:

  • Endometriosis Research and Treatment
  • Sarcoma Diagnosis and Treatment
  • Uterine Myomas and Treatments
  • Ovarian function and disorders
  • Gynecological conditions and treatments
  • Reproductive System and Pregnancy
  • Ferrocene Chemistry and Applications

Some of the frequent co-authors collaborating with Ferrari are:

  • Massimo Candiani
  • Noemi Salmeri
  • Jessica Ottolina
  • Enrico Papaleo
  • Ludovica Bartiromo

Stefano Ferrari has published multiple papers in a variety of journals, with recurring publications in the following venues:

  • European Journal of Obstetrics & Gynecology and Reproductive Biology
  • Journal of Clinical Oncology
  • Scientific Reports
  • International Journal of Molecular Sciences
  • Cancers

Noteworthy recent publications include:

  • "Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies" (2020), Journal of Medicinal Chemistry
  • "Phase III assessment of topotecan and cyclophosphamide and high-dose ifosfamide in rEECur: An international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES)." (2022), Journal of Clinical Oncology
  • "A Maltol-Containing Ruthenium Polypyridyl Complex as a Potential Anticancer Agent" (2020), Chemistry - A European Journal
  • "Concomitant autoimmunity may be a predictor of more severe stages of endometriosis" (2021), Scientific Reports
  • "Fertility Outcome after CO2 Laser Vaporization versus Cystectomy in Women with Ovarian Endometrioma: A Comparative Study" (2020), Journal of Minimally Invasive Gynecology

Their research contributions indicate an interdisciplinary approach combining clinical studies, molecular chemistry, and oncology. The work on ruthenium complexes integrates materials chemistry into anticancer drug development. Further, the clinical trials and observational studies contribute to understanding treatment outcomes in gynecological disorders and sarcoma management.

Best Publications

  • Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment

    Benedetto Sacchetti;Alessia Funari;Stefano Michienzi;Silvia Di Cesare

  • PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration

    J M Wood;G Bold;E Buchdunger;R Cozens

  • Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

    Arianna Dellavalle;Maurilio Sampaolesi;Rossana Tonlorenzi;Enrico Tagliafico

  • Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells

    Fulvio Mavilio;Graziella Pellegrini;Stefano Ferrari;Francesca Di Nunzio

  • Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

    Nathalie Gaspar;Douglas S. Hawkins;Uta Dirksen;Ian J. Lewis

  • Retinitis Pigmentosa: Genes and Disease Mechanisms

    Francesco Parmeggiani;Francesco S. Sorrentino;Diego Ponzin;Vanessa Barbaro

  • Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.

    Sant Chawla;Robert Henshaw;Leanne Seeger;Edwin Choy

  • Combination of Ru(II) complexes and light: new frontiers in cancer therapy

    Cristina Mari;Vanessa Pierroz;Stefano Ferrari;Gilles Gasser

  • Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

    Stefano Ferrari;Sigbjorn Smeland;Mario Mercuri;Franco Bertoni

  • Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report

    Gaetano Bacci;Stefano Ferrari;Franco Bertoni;Pietro Ruggieri

  • Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

    Alessandro Gronchi;Stefano Ferrari;Vittorio Quagliuolo;Javier Martin Broto

  • Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease.

    Monica Bacci;Annalisa Capobianco;Antonella Monno;Lucia Cottone

  • Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability

    Said Hashemolhosseini;Yoshikuni Nagamine;Simon J. Morley;Sylvane Desrivières

  • ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo.

    S Ferrari;E Moro;A Pettenazzo;J P Behr

  • Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

    Stefano Ferrari;Antonio Briccoli;Mario Mercuri;Franco Bertoni

  • Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

    Giovanni Grignani;Emanuela Palmerini;Virginia Ferraresi;Lorenzo D'Ambrosio

  • New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

    Bold G;Altmann Kh;Frei J;Lang M

  • Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid

    Vanessa Pierroz;Tanmaya Joshi;Anna Leonidova;Cristina Mari

  • Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase

    Lovorka Stojic;Nina Mojas;Petr Cejka;Massimiliano di Pietro

  • Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.

    P Picci;T Böhling;G Bacci;S Ferrari

Frequent Co-Authors

Vincenzo Piuri
Vincenzo Piuri University of Milan
Gilles Gasser
Gilles Gasser Chimie ParisTech
Pascal Furet
Pascal Furet Novartis (Switzerland)
Duncan M. Geddes
Duncan M. Geddes Imperial College London
Uta Griesenbach
Uta Griesenbach National Institutes of Health
Eric W.F.W. Alton
Eric W.F.W. Alton National Institutes of Health
Bernhard Spingler
Bernhard Spingler University of Zurich
Michele De Luca
Michele De Luca University of Modena and Reggio Emilia
Sergio Ferrari
Sergio Ferrari University of Modena and Reggio Emilia
Giulio Cossu
Giulio Cossu University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring Biology and Biochemistry, a range of online degree options and professional certifications in the healthcare and life sciences fields are available. These paths can help you transition into specialized roles or accelerate your career advancement.

If you are interested in mental health, consider looking into the shortest pmhnp program to quickly become a Psychiatric Mental Health Nurse Practitioner. Those with a master's degree in nursing may advance their practice by enrolling in the fastest post master's fnp certificate program. These options cater to professionals seeking efficient programs without sacrificing quality.

For students interested in nutrition and dietetics—fields closely aligned with biochemistry—the cheapest online nutrition degree option can make this pathway more affordable and accessible. Registered nurses with a science background can also expand their credentials via the rn to bsn online programs, helping them qualify for new opportunities or leadership roles.

These related online degrees and certificates not only build on your science foundation but also offer flexibility and affordability for busy professionals and students.

Best Scientists Citing Stefano Ferrari

Trending Scientists

Recently Published Articles